Shopping Cart 0
Cart Subtotal

Ypsomed Holding AG (YPSN) - Product Pipeline Analysis, 2018 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies



Ypsomed Holding AG (Ypsomed) is a medical device company that designs, develops and manufactures injection and infusion systems for self-medication and offers related services. It offers autoinjectors, dual chamber pens, and pen injectors. The company also offers services ranging from design and development projects, flexible prototyping, human factors engineering, and IP landscape management to manufacturing and assembly infrastructure and registration support. Ypsomed offers its solutions to physicians, and pharmaceutical and biotechnology companies. The company's products find application in the treatment of diabetes, infertility, growth disorders and various other clinical indications. The company operates through its subsidiaries and distributors across the world. Ypsomed operates along with its subsidiaries in Europe, Asia and Australia. Ypsomed is headquartered in Burgdorf, Switzerland.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Ypsomed Holding AG

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company


Table Of Content


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Ypsomed Holding AG Company Overview 4

Ypsomed Holding AG Company Snapshot 4

Ypsomed Holding AG Pipeline Products and Ongoing Clinical Trials Overview 4

Ypsomed Holding AG-Pipeline Analysis Overview 6

Business Description 6

Ypsomed Holding AG-Key Facts 7

Ypsomed Holding AG-Major Products and Services 8

Ypsomed Holding AG Pipeline Products by Development Stage 10

Ypsomed Holding AG Pipeline Products Overview 12

Lanzi 12

Lanzi Product Overview 12

mylife YpsoPod Insulin Pump-Tubeless 13

mylife YpsoPod Insulin Pump-Tubeless Product Overview 13

mylife YpsoPump 14

mylife YpsoPump Product Overview 14

YpsoDose 15

YpsoDose Product Overview 15

Ypsomed Holding AG-Key Competitors 16

Ypsomed Holding AG-Key Employees 17

Ypsomed Holding AG-Key Employee Biographies 18

Ypsomed Holding AG-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Ypsomed Holding AG, Recent Developments 20

Jun 29, 2018: Topping-out ceremony at the new Ypsomed site in Schwerin 20

Jun 27, 2018: Change in the Board of Directors of the Ypsomed Group 20

May 24, 2018: Ypsomed significantly increases turnover and invests more in the future 20

Mar 27, 2018: Ypsomed Expands to North America 22

Nov 09, 2017: Ypsomed Grows during First half-year and Raises its Forecast for the Year 22

Oct 24, 2017: Ypsomed supplies Bigfoot Biomedical with infusion sets 24

Oct 10, 2017: Ypsomed opens up new markets 24

Sep 28, 2017: Ypsomed''s ServoPen for the treatment of Parkinson''s disease 25

Sep 27, 2017: Go-ahead for Ypsomed's new production facility in Schwerin 25

May 24, 2017: Ypsomed accelerates growth significantly 25

Appendix 28

Methodology 28

About GlobalData 31

Contact Us 31

Disclaimer 31

List Of Figure

List of Figures

Ypsomed Holding AG Pipeline Products by Equipment Type 5

Ypsomed Holding AG Pipeline Products by Development Stage 10

List Of Table

List of Tables

Ypsomed Holding AG Pipeline Products and Ongoing Clinical Trials Overview 4

Ypsomed Holding AG Pipeline Products by Equipment Type 5

Ypsomed Holding AG Pipeline Products by Indication 5

Ypsomed Holding AG, Key Facts 7

Ypsomed Holding AG, Major Products and Services 8

Ypsomed Holding AG Number of Pipeline Products by Development Stage 10

Ypsomed Holding AG Pipeline Products Summary by Development Stage 11

Lanzi-Product Status 12

Lanzi-Product Description 12

mylife YpsoPod Insulin Pump-Tubeless-Product Status 13

mylife YpsoPod Insulin Pump-Tubeless-Product Description 13

mylife YpsoPump-Product Status 14

mylife YpsoPump-Product Description 14

YpsoDose-Product Status 15

YpsoDose-Product Description 15

Ypsomed Holding AG, Key Employees 17

Ypsomed Holding AG, Key Employee Biographies 18

Ypsomed Holding AG, Subsidiaries 19

Glossary 30

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to

Products and Companies


Ypsomed Holding AG, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies



Novo Nordisk AS

Medtronic Plc

Johnson & Johnson

F. Hoffmann-La Roche Ltd

Eli Lilly and Co

Abbott Laboratories